SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen

Cellular and Molecular Life Sciences

Volumn 64, Issue 7-8, 2007, Pages 803-814

  Lowe, D B ^a   Shearer, M H ^a   Jumper, C A ^a,b   Kennedy, R C ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b Southwest Cancer Treatment and Research Center   (United States)

Author keywords

Brain neoplasm; Cancer; immunotherapy; Malignant pleural mesothelioma; Osteosarcoma; non Hodgkin lymphoma; Simian virus 40; Simian virus 40 large tumor antigen

Indexed keywords

DNA VACCINE; ORAL POLIOMYELITIS VACCINE; RECOMBINANT VACCINE; VIRUS LARGE T ANTIGEN;

ANTIBODY RESPONSE; B LYMPHOCYTE ACTIVATION; BK VIRUS; BRAIN TUMOR; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CD4+ T LYMPHOCYTE; CELL IMMORTALIZATION; CHOROID PLEXUS TUMOR; DNA IMMUNIZATION; DNA SEQUENCE; EPENDYMOMA; HUMAN; LUNG TUMOR; MALIGNANT MESOTHELIOMA; MALIGNANT TRANSFORMATION; MEDULLOBLASTOMA; MOLECULAR INTERACTION; NONHODGKIN LYMPHOMA; NONHUMAN; OSTEOSARCOMA; PLEURA MESOTHELIOMA; POLYMERASE CHAIN REACTION; REVIEW; SEROPREVALENCE; SIMIAN VIRUS 40; TH2 CELL; TUMOR IMMUNITY; VIRAL CONTAMINATION; VIRION; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS LIKE AGENT; VIRUS TRANSMISSION;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CANCER VACCINES; HUMANS; IMMUNOTHERAPY; NEOPLASMS; POLYOMAVIRUS INFECTIONS; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS;

ANIMALIA; POLIOVIRUS; SIMIAN VIRUS 40;

EID: 34247174774     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-6414-6     Document Type: Review

References (134)

1. Sweet, B.H. and Hilleman, M.R. (1960) The vacuolating virus, S.V. 40. Proc. Soc. Exp. Biol. Med. 105, 420-427.
2. Shah, K. and Nathanson, N. (1976) Human exposure to SV40: review and comment. Am. J. Epidemiol. 103, 1-12.
3. Cutrone, R., Lednicky, J., Dunn, G., Rizzo, P., Bocchetta, M., Chumakov, K., Minor, P. and Carbone, M. (2005) Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res. 65, 10273-10279.
4. Gerber, P., Hottle, G.A. and Grubbs, R.E. (1961) Inactivation of vacuolating virus (SV-40) by formaldehyde. Proc. Soc. Exp. Biol. Med. 108, 205-209.
5. Eddy, B.E., Borman, G.S., Berkeley, W.H. and Young, R.D. (1961) Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc. Soc. Exp. Biol. Med. 107, 191-197.
6. Eddy, B.E., Borman, G.S., Grubbs, G.E. and Young, R.D. (1962) Identification of the oncogenic substance in rhesus monkey kidney cell culture as simian virus 40. Virology 17, 65-75.
7. Girardi, A.J., Sweet, B.H., Slotnick, V.B. and Hilleman, M.R. (1962) Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV-40. Proc. Soc. Exp. Biol. Med. 109, 649-660.
8. Kirschstein, R.L. and Gerber, P. (1962) Ependymomas produced after intracerebral inoculation of SV40 into newborn hamsters. Nature 195, 299-300.
9. Shein, H.M. and Enders, J.F. (1962) Transformation induced by simian virus 40 in human renal cell cultures. I. Morphology and growth characteristics. Proc. Natl. Acad. Sci. USA 48, 1164-1172.
10. Jensen, F., Koprowski, H. and Ponten, J.A. (1963) Rapid transformation of human fibroblastcultures bysimian virus. Proc. Natl. Acad. Sci. USA 50, 343-348.
11. Jensen, F., Koprowski, H., Pagano, J.S., Ponten, J. and Ravdin, R.G. (1964) Autologous and homologous implantation of human cells transformed in vitro by SV40. J. Natl. Cancer Inst. 32, 917-937.
12. Fraumeni, J.F., Jr., Ederer, F. and Miller, R.W. (1963) An evaluation of the carcinogenicity of simian virus 40 in man. JAMA 185, 713-718.
13. Stewart, A.M. and Hewitt, D. (1965) Aetiology of childhood leukaemia. Lancet 2, 789-790.
14. Morris, J.A., Johnson, K.M., Aulisio, C.G., Chanock, R.M. and Knight, V. (1961) Clinical and serologic responses in volunteers given vacuolating virus (SV-40) by respiratory route. Proc. Soc. Exp. Biol. Med. 108, 56-59.
15. Melnick, J.L. and Stinebaugh, S. (1962) Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc. Soc. Exp. Biol. Med. 109, 965-968.
16. Gerber, P. (1967) Patterns of antibodies to SV40 in children following the last booster with inactivated poliomyelitis vaccines. Proc. Soc. Exp. Biol. Med. 125, 1284-1287.
17. Heinonen, O.P., Shapiro, S., Monson, R.R., Hartz, S.C., Rosenberg, L. and Slone, D. (1973) Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int. J. Epidemiol. 2, 229-235.
18. Soriano, F., Shelburne, C.E. and Gokcen, M. (1974) Simian virus 40 in a human cancer. Nature 249, 421-424.
19. Weiner, L.P., Herndon, R.M., Narayan, O., Johnson, R.T., Shah, K., Rubinstein, L.J., Preziosi, T.J. and Conley, F.K. (1972) Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N. Engl. J. Med. 286, 385-390.
20. Narayan, O. and Weiner, L.P. (1974) Biological properties of two strains of Simian virus 40 isolated from patients with progressive multifocal leukoencephalopathy. Infect. Immun. 10, 173-179.
21. Weber, T. and Major, E.O. (1997) Progressive multifocal leukoencephalopathy: molecular biology, pathogenesis and clinical impact. Intervirology 40, 98-111.
22. Weiss, A.F., Portmann, R., Fischer, H., Simon, J. and Zang, K.D. (1975) Simian virus 40-related antigens in three human meningiomas with defined chromosome loss. Proc. Natl. Acad. Sci. U S A 72, 609-613.
23. Tabuchi, K., Kirsch, W.M., Low, M., Gaskin, D., Van Buskirk, J. and Maa, S. (1978) Screening of human brain tumors for SV40-related Tantigen. Int. J. Cancer 21, 12-17.
24. Meinke, W., Goldstein, D.A. and Smith, R.A. (1979) Simian virus 40-related DNA sequences in a human brain tumor. Neurology 29, 1590-1594.
25. Scherneck, S., Rudolph, M., Geissler, E., Vogel, F., Lubbe, L., Wahlte, H., Nisch, G., Weickmann, F. and Zimmermann, W. (1979) Isolation of a SV40-like Papovavirus from a human glioblastoma. Int. J. Cancer 24, 523-531.
26. Greenlee, J.E., Becker, L.E., Narayan, O. and Johnson, R.T. (1978) Failure to demonstrate papovavirus tumor antigen in human cerebral neoplasms. Ann. Neurol. 3, 479-481.
27. Fraumeni, J.F., Jr., Stark, C.R., Gold, E. and Lepow, M.L. (1970) Simian virus 40 in polio vaccine: follow-up of newborn recipients. Science 167, 59-60.
28. Innis, M.D. (1968) Oncogenesis and poliomyelitis vaccine. Nature 219, 972-973.
29. Farwell, J.R., Dohrmann, G.J., Marrett, L.D. and Meigs, J.W. (1979) Effect of SV40 virus-contaminated polio vaccine on the incidence and type of CNS neoplasms in children: a population-based study. Trans. Am. Neurol. Assoc. 104, 261-264.
30. Mortimer, E.A., Jr., Lepow, M.L., Gold, E., Robbins, F.C., Burton, G.J. and Fraumeni, J.F., Jr. (1981) Long-term followup of persons inadvertently inoculatedwith SV40 as neonates. N. Engl. J. Med. 305, 1517-1518.
31. Geissler, E. (1990) SV40 and human brain tumors. Prog. Med. Virol. 37, 211-222.
32. Olin, P. and Giesecke, J. (1998) Potential exposure to SV40 in polio vaccines used in Sweden during 1957: noimpact on cancer incidence rates 1960 to 1993. Dev. Biol. Stand. 94, 227-233.
33. Strickler, H.D., Rosenberg, P.S., Devesa, S.S., Hertel, J., Fraumeni, J.F., Jr. and Goedert, J.J. (1998) Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 279, 292-295.
34. Fisher, S.G., Weber, L. and Carbone, M. (1999) Cancer risk associated with simian virus 40 contaminated polio vaccine. Anticancer Res. 19, 2173-2180.
35. Strickler, H.D., Rosenberg, P.S., Devesa, S.S., Fraumeni, J.F., Jr. and Goedert, J.J. (1999) Contamination of poliovirus vaccine with SV40 and the incidence of medulloblastoma. Med. Pediatr. Oncol. 32, 77 -78.
36. Carroll-Pankhurst, C., Engels, E.A., Strickler, H.D., Goedert, J.J., Wagner, J. and Mortimer, E.A., Jr. (2001) Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period. Br. J. Cancer 85, 1295-1297.
37. Stratton, K.R., Alamario, D.A. and McCormick, M.C., Eds. (2002), Immunization Safety Review: SV40Contamination of Polio Vaccine and Cancer, National Academies Press, Washington, DC.
38. Imperiale, M.J. (2000) The human polyomaviruses, BKVand JCV: molecular pathogenesis of acute disease and potential role in cancer. Virology 267, 1-7.
39. Viscidi, R.P., Rollison, D.E., Viscidi, E., Clayman, B., Rubalcaba, E., Daniel, R., Major, E.O. and Shah, K.V. (2003) Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-likeparticle-based enzyme immunoassays. Clin. Diagn. Lab. Immunol. 10, 278-285.
40. Butel, J.S. and Lednicky, J.A. (1999) Cell and molecular biology of simian virus 40: implications for human infections and disease. J. Natl. Cancer Inst. 91, 119-134.
41. Garcea, R.L. and Imperiale, M.J. (2003) Simian virus 40 infection of humans. J. Virol. 77, 5039-5045.
42. Shah, K.V. (2000) Does SV40 infection contribute to the development of human cancers? Rev. Med. Virol. 10, 31-43.
43. Murakami, Y., Wobbe, C.R., Weissbach, L., Dean, F.B. and Hurwitz, J. (1986) Role of DNA polymerase alpha and DNA primase in simian virus 40 DNA replication in vitro. Proc. Natl. Acad. Sci. U S A 83, 2869-2873.
44. Gazdar, A.F., Butel, J.S. and Carbone, M. (2002) SV40 and human tumours: myth, association or causality? Nat. Rev. Cancer 2, 957-964.
45. Diamandopoulos, G.T. (1972) Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 176, 173-175.
46. Cicala, C., Pompetti, F. and Carbone, M. (1993) SV40 induces mesotheliomas in hamsters. Am. J. Pathol. 142, 1524-1533.
47. Krieg, P., Amtmann, E., Jonas, D., Fischer, H., Zang, K. and Sauer, G. (1981) Episomal simian virus 40 genomes in human brain tumors. Proc. Natl. Acad. Sci. USA 78, 6446-6450.
48. Ibelgaufts, H. and Jones, K.W. (1982) Papovavirus-related RNA sequences in human neurogenic tumours. Acta. Neuropathol. (Berl) 56, 118-122.
49. Vilchez, R.A., Kozinetz, C.A., Arrington, A.S., Madden, C.R. and Butel, J.S. (2003) Simian virus 40 in human cancers. Am. J. Med. 114, 675-684.
50. Bergsagel, D.J., Finegold, M.J., Butel, J.S., Kupsky, W.J. and Garcea, R.L. (1992) DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N. Engl. J. Med. 326, 988-993.
51. Lednicky, J.A., Garcea, R.L., Bergsagel, D.J. and Butel, J.S. (1995) Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 212, 710-717.
52. Huang, H., Reis, R., Yonekawa, Y., Lopes, J.M., Kleihues, P. and Ohgaki, H. (1999) Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol. 9, 33-42.
53. Martini, F., Iaccheri, L., Lazzarin, L., Carinci, P., Corallini, A., Gerosa, M., Iuzzolino, P., Barbanti-Brodano, G. and Tognon, M. (1996) SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res. 56, 4820-4825.
54. Kouhata, T., Fukuyama, K., Hagihara, N. and Tabuchi, K. (2001) Detection of simian virus 40 DNA sequence in human primary glioblastomas multiforme. J. Neurosurg. 95, 96-101.
55. Martini, F., Lazzarin, L., Iaccheri, L., Vignocchi, B., Finocchiaro, G., Magnani, I., Serra, M., Scotlandi, K., Barbanti-Brodano, G. and Tognon, M. (2002) Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. Cancer 94, 1037-1048.
56. Arrington, A.S., Moore, M.S. and Butel, J.S. (2004) SV40-positive brain tumor in scientist with risk of laboratory exposure to the virus. Oncogene 23, 2231-2235.
57. Weggen, S., Bayer, T.A., von Deimling, A., Reifenberger, G., von Schweinitz, D., Wiestler, O.D. and Pietsch, T. (2000) Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol. 10, 85-92.
58. Engels, E.A., Sarkar, C., Daniel, R.W., Gravitt, P.E., Verma, K., Quezado, M. and Shah, K.V. (2002) Absence of simian virus 40 in human brain tumors from northern India. Int. J. Cancer 101, 348-352.
59. Rollison, D.E., Utaipat, U., Ryschkewitsch, C., Hou, J., Goldthwaite, P., Daniel, R., Helzlsouer, K.J., Burger, P.C., Shah, K.V. and Major, E.O. (2005) Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories. Int. J. Cancer 113, 769-774.
60. Carbone, M., Rizzo, P., Procopio, A., Giuliano, M., Pass, H.I., Gebhardt, M.C., Mangham, C., Hansen, M., Malkin, D.F., Bushart, G., et al. (1996) SV40-like sequences in human bone tumors. Oncogene 13, 527-535.
61. Kleihues, P., Schauble, B., zur Hausen, A., Esteve, J. and Ohgaki, H. (1997) Tumors associated with p53 germline mutations: a synopsis of 91 families. Am. J. Pathol. 150, 1-13.
62. Varley, J.M., Evans, D.G. and Birch, J.M. (1997) Li-Fraumeni syndrome-a molecular and clinical review. Br. J. Cancer 76, 1-14.
63. Lednicky, J.A., Stewart, A.R., Jenkins, J.J., 3rd, Finegold, M.J. and Butel, J.S. (1997) SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes. Int. J. Cancer 72, 791-800.
64. Mendoza, S.M., Konishi, T. and Miller, C.W. (1998) Integration of SV40 in human osteosarcoma DNA. Oncogene 17, 2457-2462.
65. Yamamoto, H., Nakayama, T., Murakami, H., Hosaka, T., Nakamata, T., Tsuboyama, T., Oka, M., Nakamura, T. and Toguchida, J. (2000) High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients. Br. J. Cancer 82, 1677-1681.
66. Mitsuyasu, R. (1999) Oncological complications of human immunodeficiency virus disease and hematologic consequences of their treatment. Clin. Infect. Dis. 29, 35-43.
67. Shivapurkar, N., Harada, K., Reddy, J., Scheuermann, R.H., Xu, Y., McKenna, R.W., Milchgrub, S., Kroft, S.H., Feng, Z. and Gazdar, A.F. (2002) Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 359, 851-852.
68. Vilchez, R.A., Madden, C.R., Kozinetz, C.A., Halvorson, S.J., White, Z.S., Jorgensen, J.L., Finch, C.J. and Butel, J.S. (2002) Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 359, 817-823.
69. Shivapurkar, N., Takahashi, T., Reddy, J., Zheng, Y., Stastny, V., Collins, R., Toyooka, S., Suzuki, M., Parikh, G., Asplund, S., Timmons, C., et al. (2004) Presence of simian virus 40DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer Res. 64, 3757-3760.
70. Vilchez, R.A., Lopez-Terrada, D., Middleton, J.R., Finch, C.J., Killen, D.E., Zanwar, P., Jorgensen, J.L. and Butel, J.S. (2005) Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related non-Hodgkin's lymphoma. Virology 342, 38-46.
71. de Sanjose, S., Shah, K.V., Domingo-Domenech, E., Engels, E.A., Fernandez de Sevilla, A., Alvaro, T., Garcia-Villanueva, M., Romagosa, V., Gonzalez-Barca, E. and Viscidi, R.P. (2003) Lack of serological evidence for an association between simian virus 40 and lymphoma. Int. J. Cancer 104, 522-524.
72. Engels, E.A., Viscidi, R.P., Galloway, D.A., Carter, J.J., Cerhan, J.R., Davis, S., Cozen, W., Severson, R.K., de Sanjose, S., Colt, J.S. et al. (2004) Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J. Natl. Cancer Inst. 96, 1368-1374.
73. Engels, E.A., Chen, J., Hartge, P., Cerhan, J.R., Davis, S., Severson, R.K., Cozen, W. and Viscidi, R.P. (2005) Antibody responses to simian virus 40 Tantigen: a case-control study of non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 14, 521-524.
74. Rollison, D.E., Helzlsouer, K.J., Halsey, N.A., Shah, K.V. and Viscidi, R.P. (2005) Markers of past infection with simian virus 40 (SV40) and risk of incident non-Hodgkin lymphoma in a Maryland cohort. Cancer Epidemiol. Biomarkers Prev. 14, 1448-1452.
75. David, H., Mendoza, S., Konishi, T. and Miller, C.W. (2001) Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett. 162, 57-64.
76. MacKenzie, J., Wilson, K.S., Perry, J., Gallagher, A. and Jarrett, R.F. (2003) Association between simian virus 40DNA and lymphoma in the United kingdom. J. Natl. Cancer Inst. 95, 1001-1003.
77. Hernandez-Losa, J., Fedele, C.G., Pozo, F., Tenorio, A., Fernandez, V., Castellvi, J., Parada, C. and Ramon y Cajal, S. (2005) Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas. Cancer 103, 293-298.
78. Sui, L.F., Williamson, J., Lowenthal, R.M. and Parker, A.J. (2005) Absence of simian virus 40 (SV40) DNA in lymphoma samples from Tasmania, Australia. Pathology 37, 157-159.
79. Schuler, F., Dolken, S.C., Hirt, C., Dolken, M.T., Mentel, R., Gurtler, L.G. and Dolken, G. (2006) No evidence for simian virus 40 DNA sequences in malignant non-Hodgkin lymphomas. Int. J. Cancer 118, 498-504.
80. Robinson, B.W. and Lake, R.A. (2005) Advances inmalignant mesothelioma. N. Engl. J. Med. 353, 1591-1603.
81. Carbone, M., Pass, H.I., Rizzo, P., Marinetti, M., Di Muzio, M., Mew, D.J., Levine, A.S. and Procopio, A. (1994) Simian virus 40-likeDNAsequences in human pleural mesothelioma. Oncogene 9, 1781-1790.
82. Carbone, M., Rizzo, P., Grimley, P.M., Procopio, A., Mew, D.J., Shridhar, V., de Bartolomeis, A., Esposito, V., Giuliano, M.T., Steinberg, S.M. et al. (1997) Simian virus-40 large-T antigen binds p53 in human mesotheliomas.Nat. Med. 3, 908-912.
83. De Luca, A., Baldi, A., Esposito, V., Howard, C.M., Bagella, L., Rizzo, P., Caputi, M., Pass, H.I., Giordano, G.G., Baldi, F. et al. (1997) The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat. Med. 3, 913-916.
84. Suzuki, M., Toyooka, S., Shivapurkar, N., Shigematsu, H., Miyajima, K., Takahashi, T., Stastny, V., Zern, A.L., Fujisawa, T., Pass, H.I., et al. (2005) Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene 24, 1302-1308.
85. Bocchetta, M., Di Resta, I., Powers, A., Fresco, R., Tosolini, A., Testa, J.R., Pass, H.I., Rizzo, P. and Carbone, M. (2000) Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc. Natl. Acad. Sci. USA 97, 10214-10219.
86. Waheed, I., Guo, Z.S., Chen, G.A., Weiser, T.S., Nguyen, D.M. and Schrump, D.S. (1999) Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigenpositive human pleural mesothelioma cells. Cancer Res. 59, 6068-6073.
87. Foddis, R., De Rienzo, A., Broccoli, D., Bocchetta, M., Stekala, E., Rizzo, P., Tosolini, A., Grobelny, J.V., Jhanwar, S.C., Pass, H.I. et al. (2002) SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 21, 1434-1442.
88. Carbone, M., Kratzke, R.A. and Testa, J.R. (2002) The pathogenesis of mesothelioma. Semin. Oncol. 29, 2-17.
89. Hirvonen, A., Mattson, K., Karjalainen, A., Ollikainen, T., Tammilehto, L., Hovi, T., Vainio, H., Pass, H.I., Di Resta, I., Carbone, M. et al. (1999) Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol. Carcinog. 26, 93-99.
90. Emri, S., Kocagoz, T., Olut, A., Gungen, Y., Mutti, L. and Baris, Y.I. (2000) Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey. Anticancer Res. 20, 891-894.
91. De Rienzo, A., Tor, M., Sterman, D.H., Aksoy, F., Albelda, S.M. and Testa, J.R. (2002)Detection of SV40DNAsequences in malignant mesothelioma specimens from the United States, but not from Turkey. J. Cell. Biochem. 84, 455-459.
92. Leithner, A., Weinhaeusel, A., Windhager, R., Schlegl, R., Waldner, P., Lang, S., Dominkus, M., Zoubek, A., Popper, H.H. and Haas, O.A. (2002) Absence of SV40 in Austrian tumors correlates with low incidence of mesotheliomas. Cancer Biol. Ther. 1, 375-379.
93. Carbone, M., Pass, H.I., Miele, L. and Bocchetta, M. (2003) New developments about the association of SV40 with human mesothelioma. Oncogene 22, 5173-5180.
94. Strickler, H.D., Goedert, J.J., Fleming, M., Travis, W.D., Williams, A.E., Rabkin, C.S., Daniel, R.W. and Shah, K.V. (1996) Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol. Biomarkers Prev. 5, 473-475.
95. Jasani, B. (1999) Simian virus 40 and human pleural mesothelioma. Thorax 54, 750-751.
96. Mulatero, C., Surentheran, T., Breuer, J. and Rudd, R.M. (1999) Simian virus 40 and human pleural mesothelioma. Thorax 54, 60-61.
97. Strickler, H.D. (2001) A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens. Cancer Epidemiol. Biomarkers Prev. 10, 523-532.
98. MacLachlan, D.S. (2002) SV40 in human tumors: new documents shed light on the apparent controversy. Anticancer Res. 22, 3495-34999.
99. Dhaene, K., Verhulst, A. and Van Marck, E. (1999) SV40 large T-antigen and human pleural mesothelioma. Screening by polymerase chain reaction and tyramine-amplified immunohistochemistry. Virchows Arch. 435, 1-7.
100. Hubner, R. and Van Marck, E. (2002) Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium). Cancer Causes Control 13, 121-129.
101. Mayall, F., Barratt, K. and Shanks, J. (2003) The detection of Simian virus 40 in mesotheliomas from New Zealand and England using real time FRET probe PCR protocols. J. Clin. Pathol. 56, 728-730.
102. Manfredi, J.J., Dong, J., Liu, W.J., Resnick-Silverman, L., Qiao, R., Chahinian, P., Saric, M., Gibbs, A.R., Phillips, J.I., Murray, J. et al. (2005) Evidence against a role for SV40 in human mesothelioma. Cancer Res. 65, 2602-2609.
103. Watts, A.M., Shearer, M.H., Pass, H.I. and Kennedy, R.C. (1997) Development of an experimental murine pulmonary metastasis model incorporating a viral encoded tumor specific antigen. J. Virol. Methods 69, 93-102.
104. Watts, A.M. and Kennedy, R.C. (1998) Quantitation of tumor foci in an experimental murine tumor model using computerassisted video imaging. Anal. Biochem. 256, 217-219.
105. Kennedy, R.C., Shearer, M.H., Watts, A.M. and Bright, R.K. (2003) CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen. Cancer Res. 63, 1040-1045.
106. Lowe, D.B., Shearer, M.H., Tarbox, J.A., Kang, H.S., Jumper, C.A., Bright, R.K. and Kennedy, R.C. (2005) In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization. Virology 332, 28 -37.
107. Lowe, D.B., Shearer, M.H. and Kennedy, R.C. (2006) DNA vaccines: successes and limitations in cancer and infectious disease. J. Cell. Biochem. 98, 235-242.
108. Scheurer, M.E., Tortolero-Luna, G. and Adler-Storthz, K. (2005) Human papillomavirus infection: biology, epidemiology, and prevention. Int. J. Gynecol. Cancer 15, 727-746.
109. Shah, K.V., Daniel, R.W., Strickler, H.D. and Goedert, J.J. (1997) Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus. J. Infect. Dis. 176, 1618-1621.
110. Bofill-Mas, S., Pina, S. and Girones, R. (2000) Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl. Environ. Microbiol. 66, 238-245.
111. Vastag, B. (2002) Sewage yields clues to SV40 transmission. JAMA 288, 1337-1338.
112. Butel, J.S., Arrington, A.S., Wong, C., Lednicky, J.A. and Finegold, M.J. (1999) Molecular evidence of simian virus 40 infections in children. J. Infect. Dis. 180, 884-887.
113. Li, R.M., Branton, M.H., Tanawattanacharoen, S., Falk, R.A., Jennette, J.C. and Kopp, J.B. (2002) Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J. Am. Soc. Nephrol. 13, 2320-2330.
114. Comar, M., D'Agaro, P., Andolina, M., Maximova, N., Martini, F., Tognon, M. and Campello, C. (2004) Hemorrhagic cystitis in children undergoing bone marrow transplantation: a putative role for simian virus 40. Transplantation 78, 544-548.
115. Horvath, L.B. (1972) SV40 neutralizing antibodies in the sera of man and experimental animals. Acta Virol. 16, 141-146.
116. Shah, K.V. (1972) Evidence for an SV40-related papovavirus infection of man. Am. J. Epidemiol. 95, 199-206.
117. Zimmermann, W., Scherneck, S. and Geissler, E. (1983) Quantitative determination of papovavirus IgG antibodies in sera from cancer patients, labworkers and several groups of control persons by enzyme-linked immunosorbent assay (ELISA). Zentralbl Bakteriol. Mikrobiol. Hyg. [A] 254, 187-196.
118. Engels, E.A., Switzer, W.M., Heneine, W. and Viscidi, R.P. (2004) Serologic evidence for exposure to simian virus 40 in North American zoo workers. J. Infect. Dis. 190, 2065-2069.
119. Shah, K.V., McCrumb, F.R., Jr., Daniel, R.W. and Ozer, H.L. (1972) Serologic evidence for a simian-virus-40-like infection of man. J. Natl. Cancer Inst. 48, 557-561.
120. Jafar, S., Rodriguez-Barradas, M., Graham, D.Y. and Butel, J.S. (1998) Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J.Med. Virol. 54, 276-284.
121. Butel, J.S., Wong, C., Vilchez, R.A., Szucs, G., Domok, I., Kriz, B., Slonim, D. and Adam, E. (2003) Detection of antibodies to polyomavirus SV40 in two central European countries. Cent. Eur. J. Public Health 11, 3-8.
122. Nurgalieva, Z.Z., Wong, C., Zhangabylov, A.K., Omarbekova, Z.E., Graham, D.Y., Vilchez, R.A. and Butel, J.S. (2005) Polyomavirus SV40 infections in Kazakhstan. J. Infect. 50, 142-148.
123. Shah, K.V., Ozer, H.L., Pond, H.S., Palma, L.D. and Murphy, G.P. (1971) SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature 231, 448-449.
124. Geissler, E., Konzer, P., Scherneck, S. and Zimmermann, W. (1985) Sera collected before introduction of contaminated polio vaccine contain antibodies against SV40. ActaVirol. 29, 420-423.
125. Butel, J.S., Jafar, S., Wong, C., Arrington, A.S., Opekun, A.R., Finegold, M.J. and Adam, E. (1999) Evidence of SV40 infections in hospitalized children. Hum. Pathol. 30, 1496-1502.
126. Carter, J.J., Madeleine, M.M., Wipf, G.C., Garcea, R.L., Pipkin, P.A., Minor, P.D. and Galloway, D.A. (2003) Lack of serologic evidence for prevalent simian virus 40 infection in humans. J. Natl. Cancer Inst. 95, 1522-1530.
127. Knowles, W.A., Pipkin, P., Andrews, N., Vyse, A., Minor, P., Brown, D.W. and Miller, E. (2003) Population-based study of antibody to the human polyomaviruses BKVand JCVand the simian polyomavirus SV40. J. Med. Virol. 71, 115-123.
128. Rollison, D.E., Helzlsouer, K.J., Alberg, A.J., Hoffman, S., Hou, J., Daniel, R., Shah, K.V. and Major, E.O. (2003) Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol. Biomarkers Prev. 12, 460-463.
129. Griffiths, D.J., Nicholson, A.G. and Weiss, R.A. (1998) Detection of SV40 sequences in human mesothelioma. Dev. Biol. Stand. 94, 127-36.
130. Volter, C., zur Hausen, H., Alber, D. and de Villiers, E.M. (1998) A broad spectrum PCR method for the detection of polyomaviruses and avoidance of contamination by cloning vectors. Dev. Biol. Stand. 94, 137-142.
131. Lopez-Rios, F., Illei, P.B., Rusch, V. and Ladanyi, M. (2004) Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet 364, 1157-1166.
132. Pearson, H. (2004) Monkey virus may be cleared of cancer link. Nature 431, 495.
133. Cristaudo, A., Foddis, R., Vivaldi, A., Buselli, R., Gattini, V., Guglielmi, G., Cosentino, F., Ottenga, F., Ciancia, E., Libener, R. et al. (2005) SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study. Cancer Res. 65, 3049-3052.
134. Dang-Tan, T., Mahmud, S.M., Puntoni, R. and Franco, E.L. (2004) Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association. Oncogene 23, 6535-6540.